EnVVeno Medical Corporation (NASDAQ:NVNO) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Headlines Articles Press releases EnVVeno Medical Corporation

Home
Companies
EnVVeno Medical Corporation

BRIEF

published on 09/26/2024 at 22:10, 1 month 24 days ago

EnVVeno Medical Corporation Announces Proposed Public Offering

SEC Filing Public Offering EnVVeno Medical VenoValve Venous Disease
PRESS RELEASE

published on 09/26/2024 at 22:05, 1 month 24 days ago

enVVeno Medical Corporation Announces Proposed Public Offering
enVVeno Medical Corp. proposes public stock offering through underwritten public offering for venous disease treatment products. Funding for R&D and corporate needs

Medical Devices EnVVeno Medical Corporation Venous Disease Treatment Public Stock Offering R&D Funding
BRIEF

published on 09/03/2024 at 15:05, 2 months 17 days ago

EnVVeno Medical Appoints Sandy Prietto as VP of Marketing

Medical Devices FDA Approval EnVVeno Medical VenoValve Sandy Prietto
PRESS RELEASE

published on 09/03/2024 at 15:00, 2 months 17 days ago

enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing
enVVeno Medical Corporation announces Sandy Prietto as new VP of Marketing, bringing significant MedTech marketing experience focused on Cardiovascular Devices. Company prepares for VenoValve monetization with upcoming milestones in 2024

VenoValve 2024 Milestones EnVVeno Medical Corporation Sandy Prietto VP Of Marketing
BRIEF

published on 08/14/2024 at 15:05, 3 months 6 days ago

EnVVeno Medical Updates on FDA Premarket Approval for VenoValve®

Medical Device FDA Approval EnVVeno Medical VenoValve CVI Treatment
PRESS RELEASE

published on 08/14/2024 at 15:00, 3 months 6 days ago

enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)
enVVeno Medical Corporation provides update on VenoValve PMA approval application process for FDA. Company aims to file final module in Q4 2024 after approval of 4 modules

FDA VenoValve EnVVeno Medical Corporation PMA CVI
BRIEF

published on 08/01/2024 at 14:10, 3 months 19 days ago

EnVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Financial Results FDA Approval Corporate Update Venous Disease VenoValve Trial
PRESS RELEASE

published on 08/01/2024 at 14:05, 3 months 19 days ago

enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update
enVVeno Medical Corporation reported financial results and clinical program updates for Q2 2024, including positive VenoValve trial data and progress on enVVe valve launch. Cash balance of $39.1M to fund operations till 2025

Financial Results Cash Balance VenoValve EnVVeno Medical Corporation EnVVe Valve Launch
BRIEF

published on 06/25/2024 at 15:05, 4 months 25 days ago

EnVVeno Medical to Participate in the Virtual Investor Closing Bell Series

EnVVeno Medical VenoValve SAVVE Trial Venous Disease Virtual Investor Closing Bell Series
PRESS RELEASE

published on 06/25/2024 at 15:00, 4 months 25 days ago

enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
Robert Berman, CEO of enVVeno Medical, to discuss positive venous ulcer healing data in upcoming live webcast. Learn about the VenoValve technology and company advancements

EnVVeno Medical VenoValve SAVVE Trial Robert Berman Venous Disease

Accesswire

Published on 11/21/2024 at 13:30, 22 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 22 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 52 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 52 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 52 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 37 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 17 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 37 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 45 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 52 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 54 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 32 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 7 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 7 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE